Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

Kelly Posner, Gregory K. Brown, Bárbara Stanley et al. · American Journal of Psychiatry · 2011 · 5K citations

Social Sciences, Psychiatry, Psychology +15

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

Christelle Peyron, Juliette Faraco, William M. Rogers et al. · Nature Medicine · 2000 · 2.1K citations

Life Sciences, Neurology, Neuroscience +13

Sleep Complaints Among Elderly Persons: An Epidemiologic Study of Three Communities

Daniel J. Foley, Andrew A. Monjan, Sandra Brown et al. · SLEEP · 1995 · 1.6K citations · Full text

Nursing, Geriatric Medicine, Geriatrics +14

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

David Michelson, Ellen Snyder, Erin M. Paradis et al. · The Lancet Neurology · 2014 · 509 citations

Medicine, Pharmacology, Pharmacotherapy +12

Discovery of the Dual Orexin Receptor Antagonist [(7<i>R</i>)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia

Christopher D. Cox, Michael J. Breslin, David B. Whitman et al. · Journal of Medicinal Chemistry · 2010 · 370 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12